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SUVmax of primary tumor. Tumor stages were determined by using the 
TNM staging system. Sensitivity, speciﬁcity, accuracy, and positive and 
negative predictive values for lymph node metastasis were calculated. 
Patients were divided into two groups: Group A included the SUVmax 
of primary tumor greater than or equal to 2.5(n=25) and group B lower 
than 2.5(n=56). We compare the rate of lymph node metastasis in each 
group. Statistically signiﬁcant differences in two groups were deter-
mined with P < 0.05 obtained by using chi-square test.
Result: Sensitivity, speciﬁcity, accuracy, and positive and negative pre-
dictive values for lymph node metastasis were 61%, 97%, 89%, 85%, 
90%, respectively. Nodal staging were overdiagnosed in two patients 
and underdiagnosed in 11 patients.
In group A there was only one lymph node metastasis which histologi-
cal type was lymphoepithelioma-like carcinoma. In group B there were 
17 cases with lymph node metastasis. The rate of lymph node metasta-
sis was signiﬁcantly lower in group A compared with group B.
Conclusion: PET/CT improved the diagnosis of lymph node metas-
tasis but false negative rate were still high. SUVmax was a predictor 
for lymph node metastasis and it could be a useful indicator of limited 
resection for NSCLC.
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Background: Although disseminated neoplasm has the characteristic 
pattern of multiple foci of FDG accumulation, less advanced metastatic 
disease may be difﬁcult to distinguish from benign disease. FDG-PET 
with a solitary extrathoracic abnormality can be particularly problem-
atic. The aim of this study is to assess the incidence and the nature 
of solitary extrathoracic FDG accumulation in patients with NSCLC 
staged with whole body FDG-PET scan. 
Methods: Two hundred and nine patients with NSCLC underwent 
FDG-PET scan for staging before treatment between January 2000 and 
December 2002 in KIRAMS. Among them, distant FDG accumulation 
was found in 60 patients (28.7%, 60/209), and solitary extrathoracic 
FDG accumulation in 26 (12.4%, 26/209). The patients with a solitary 
extrathoracic PET ﬁnding had further examination such as radiology 
(CT, MRI, USG, and simple X-ray), bone scan, and pathology for 
conﬁrming metastasis. 
Results: All patients (22 men, 4 women; median age, 67 years; range, 
43-85) were followed-up till October 2006. Histologic analysis re-
vealed adenocarcinoma in 14, squamous cell carcinoma in 9, other in 
3. The solitary extrathoracic FDG accumulation was localized in bone 
(18), adrenal (3), liver (2), nasopharynx (1), spleen (1), and thyroid (1). 
Finally metastases were diagnosed in 19 patients (positive predictive 
value 73.1%, 19/26).
Conclusions: Solitary extrathoracic lesion on PET scan was detected in 
12.4% of patients with pretreatment NSCLC. However, positive predic-
tive value of solitary extrathoracic FDG accumulation on PET scan 
was not satisfactory in our data. Therefore, further study for conﬁrming 
metastasis is necessary in patients with a solitary extrathoracic FDG 
accumulation. 
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Background: The purpose of this study is to analyze false-positive and 
false-negative results in the systematic use of FDG-PET in our staging 
protocol of NSCLC.
Methods: From January 2004 to September 2006, 128 patients with 
NSCLC elegible for surgery underwent FDG-PET. Patients with 
conﬁrmed distant metastases were excluded. Mediastinal lymph 
nodes (LN) were considered to be positive when increased uptake was 
observed by visual assessment as compared with that of the rest of the 
mediastinum. The result of the FDG-PET was compared with histologi-
cal ﬁndings after surgical exploration of the mediastinum (SEM), pul-
monary resection plus systematic nodal dissection (PR+SND) or both.
Results: Ten (24%) of 42 positive FDG-PET (8% of all patients) were 
false-positive (patients with negative SEM and pN0-1 after PR+SND). 
Fourteen (16%) of 86 negative FDG-PET (11% of all patients) were 
false-negative (10 underwent SEM for other reasons (large LN on CT, 
hilar uptake and central tumor): it was negative in 3 cases but ﬁnal 
staging was pN2 after PR+SND; and positive in 7 (50%) cases; 4 
patients underwent thoracotomy without SEM). Two more patients with 
ipsilateral positive FDG-PET had N3 at SEM. Sensitivity, speciﬁcity, 
negative and positive predictive values, and accuracy of FDG-PET 
were 78%, 87%, 76%, 83% and 81%, respectively. Mediastinal LN on 
CT were ≤ 1 cm in half of the false-positive FDG-PET. The histology 
was squamous cell in 7, adenocarcinoma in 2 and large cell in one. 
Histologic ﬁndings in false-positive LN were non-speciﬁc follicular 
hyperplasia, sinusal hystiocytosis or both in 8 cases, and hystologically 
normal LN in 2. False-negative FDG-PET had mediastinal LN on CT 
≥ 1 cm. in 6 cases. Their histology was adenocarcinoma in 4, large 
cell in 5, and squamous cell in 5. The two patients with false-negative 
contralateral FDG-PET had adenocarcinoma. Positive nodal stations 
in 4 patients with false-negative FDG-PET who did not undergo SEM 
were in station 7 in one patient; in stations 11R, 4R and 7 in another 
patient, in station 3 (pretracheal) in the third patient, and stations 5, 7, 
9, 10L and 11L in the last patient. All four patients had LN metastases 
foci > 2.5 mm, but two of them had LN metastases < 4 mm. Twelve pa-
tients with false-negative FDG-PET (cN3 patients included) underwent 
SEM. It was negative in 3 patients; two of them had macrometastases 
in stations 4R and 5, and one had a micrometastasis in station 7. The 
SEM was positive in the remaining 9 patients. Causative factors for 
false-negative FDG-PET were: 1) mis-localization of a mediastinal 
LN in station 4R as hilar LN in two patients; 2) weak FDG uptake in 
contralateral mediastinal macrometastatic LN, in 2 patients (station 4L 
in both); 3) weak FDG uptake in ipsilateral mediastinal or subcarinal 
Copyright © 2007 by the International Association for the Study of Lung Cancer S573
Journal of Thoracic Oncology • Volume 2, Number 8, Supplement 4, August 2007  12th World Conference on Lung Cancer
micrometastatic LN in 3 patients, and 4) weak FDG uptake in mediasti-
nal ipsilateral macrometastatic LN in 5 patients. 
Conclusions: Before therapeutic decision, an abnormal mediastinal 
FDG uptake must be conﬁrmed pathologically. In certain situations, 
SEM is also indicated when there is no abnormal uptake in the medias-
tinum. 
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Objective: Neuroendocrine (NE) lung tumors consist of typical carci-
noid (TC), atypical carcinoid (AC), large cell neuroendocrine carci-
noma (LCNEC) and small cell carcinoma (SCLC). The determinant of 
FDG uptake for NE lung tumors has not been well elucidated. The aim 
of the present study is to investigate the relationship of FDG uptake and 
glucose transporter type 1 (Glut-1) expression in NE lung tumors. 
Methods: NE lung tumor patients (n=32; age, mean ± s.d.=67.8±10y; 
male:female=28:4) who had underwent F-18 FDG-PET before treat-
ment were enrolled. There were 1 TC, 3 AC, 5 LCNEC, and 23 SCLC. 
FDG uptake was represented by maximum standardized uptake value 
(maxSUV). The parafﬁn sections of the tumor tissues were immunos-
tained for Glut-1 (Neomarker, 1:50). The relation of FDG uptake and 
Glut-1 expression was assessed by Pearson correlation analysis. 
Results: The maxSUVs of all NE lung tumors ranged from 0.6 to 29.5 
(mean±s.d.=7.7±5.4), whereas percentage Glut-1 expression ranged 
from 0 to 100% (18±24%). MaxSUVs of all NE lung tumors were 
signiﬁcantly correlated with percentage Glut-1 expression (r=0.6471, 
p=0.0001). In subgroup analyses, maxSUV was also signiﬁcantly cor-
related with Glut-1 expression in SCLC (n=23, r=0.6189, p=0.0016) 
and in non-small cell NE lung tumors (n=9, r=0.7039, p=0.0343). 
The maxSUV and the percentage Glut-1 expression were 1.7±2.0 and 
5.0±0.0%, 7.9±3.2 and 35.0±32.4%, and 7.6±3.7 and 12.6±14.1% 
for AC, LCNEC, and SCLC, respectively. MaxSUV of SCLC was 
signiﬁcantly higher than that of AC (p=0.007), but percentage Glut-1 
expression was not signiﬁcantly different among AC, LCNEC, and 
SCLC (p>0.05). One TC case had a maxSUV of 29.5 and 100% Glut-1 
expression.
Conclusions: In NE lung tumors, the maxSUV on FDG-PET was 
highly correlated with Glut-1 immunostaining positivity. This result 
suggests that Glut-1 expression is one of the determining factors of 
FDG uptake in NE lung tumors.
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Aims: To investigate whether the addition of FDG-PET to standard 
evaluation procedure alters tumour stage, mainly by detection of occult 
distant metastases, and thus has an impact on the ﬁnal treatment in 
patients planned for chemo-radiotherapy. 
Material and Methods: In June 2003 we added FDG-PET to conven-
tional evaluation of lung cancer in patients with NSCLC planned for 
high dose radiotherapy with concomitant chemotherapy. 
The routine evaluation consisted of clinical examination, chest x-ray, 
CT-scan of thorax and upper abdomen, bronchoscopy and comple-
mentary imaging as needed. The evaluation of the clinical data and 
the CT-scan was performed in a conference with the participation of 
at least one experienced pulmonary oncologist and an experienced 
chest radiologist. Based on the routine evaluation, totally 53 patients 
(32 men, 20 women) were in stage IIB-III and thus were planned for 
concomitant chemo-radiotherapy. These patients underwent FDG-PET 
as the ﬁnal part of the staging procedure.
Results: In a total of 53 patients, 10 patients (19%) were found to 
have distant metastases undiagnosed by routine evaluation. The initial 
management plan was altered in 8 cases (15%). 
Conclusion: Adding FDG-PET to routine clinical evaluation is justi-
ﬁed also in this clinical setting.
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Background: Papillary adenocarcinoma (PA) is a distinct histological 
subtype of adenocarcinoma of the lung, but its radiological ﬁndings 
have been rarely reported. Histologically, the micropapillary compo-
nent is well known characteristic feature of PA and has been found to 
be a distinct pathologic marker for poor prognosis. The purpose of this 
study is to evaluate characteristic Computed Tomographic (CT) ﬁnd-
ings of adenocarcinoma with micropapillary component (PA pattern). 
Methods: From January 2000 to February 2006, 1078 consecutive 
patients were conﬁrmed adenocarcinoma of the lung by histopathology, 
including 45 PA pattern (M:F=24:21, mean age, 59yrs). Chest CT was 
reviewed as consensus reading by two radiologists. The CT ﬁndings 
such as size, number, margin, character (consolidation or inﬁltration, 
cavity) of tumor, the presence of ground-glass opacity (GGO), spicula-
tion, lobulation, air-bronchogram, bubble lucency, and pleural tagging 
were assessed. 
Results: Dominant CT ﬁnding of PA pattern adenocarcinoma was soli-
tary mass or nodule (n=35, 78%). Another ﬁnding is central mass (n=9, 
20%) or inﬁltration (n=3, 7%). Spiculation (n=20, 44%) and lobulation 
(n=25, 56%) are common characteristics of nodules, however, GGO 
(n=9, 20%) and air-bronchogram or bubble lucency (n=12, 27%) is less 
